PROCEPT BioRobotics' HYDROS System Gets FDA Clearance - Quest Diagnostics ( NYSE:DGX ) , ABM Indus ( NYSE:ABM )
PROCEPT BioRobotics PRCT recently announced FDA 510 ( k ) clearance of its next-generation platform, the HYDROS Robotic System. This clearance marks an important achievement for PROCEPT BioRobotics as Aquablation therapy continues its rapid adoption, with more than 400 robotic systems now ...
| Ticker |
Sentiment |
Impact |
|
ABM
|
Neutral
|
22 %
|
|
DGX
|
Somewhat Bullish
|
27 %
|
|
PRCT
|
Somewhat Bullish
|
22 %
|
